Search

everythinglearnresearchcommunity

for

Search:↓

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tiny pollution particles called PM2.5 can harm skin cells by causing stress, damage to cell parts, and cell death.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Tight junctions are key for skin protection and controlling what gets absorbed or passes through the skin.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Nutraceuticals may improve skin health and protect against aging, but more research is needed on their optimal use and possible health risks.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

New treatments for male hypogonadism are effective and should be personalized.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.